Insider Transactions in Q4 2021 at Impel Pharmaceuticals Inc (IMPL)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2021
|
John Hoekman Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+13.49%
|
$20,000
$1.64 P/Share
|
|
Nov 19
2021
|
Timothy S Nelson |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$100,000
$10.76 P/Share
|